ClinicalTrials.gov
ClinicalTrials.gov Menu

Screening Brief Intervention Referral to Treatment (SBIRT) in New Mexico

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01131520
Recruitment Status : Completed
First Posted : May 27, 2010
Results First Posted : August 21, 2017
Last Update Posted : December 12, 2017
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Friends Research Institute, Inc.

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to compare the effectiveness in reducing drug use and its associated problems of a brief intervention for drug use delivered by a behavioral health counselor as compared to a brief intervention delivered by a computerized intervention.

Condition or disease Intervention/treatment Phase
Drug Abuse HIV Risk Behavior Behavioral: Computerized brief intervention Behavioral: Counselor delivered brief intervention Not Applicable

Detailed Description:
Drug use is a significant cause of morbidity and mortality in the United States. Efforts to develop and rigorously evaluate methods to provide Screening, Brief Intervention and Referral to Treatment (SBIRT) for drug users are needed. Computerized screening and brief interventions in particular have the potential to circumvent some of the potential problems of integrating SBIRT delivered by a counselor into busy primary care settings. These interventions may reduce drug use among individuals who are using drugs but are not yet drug dependent.

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 360 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: SBIRT in New Mexico
Study Start Date : June 2010
Actual Primary Completion Date : December 2012
Actual Study Completion Date : July 2015
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Computerized Brief Intervention
Computerized one-session brief intervention for drug use
 Behavioral: Computerized brief intervention
This is a brief computerized intervention focused on drug use of patients receiving primary care treatment in an outpatient setting. The intervention is delivered in one session.
Active Comparator: Counselor delivered brief intervention
This is a brief intervention focused on drug use delivered by a behavioral health counselor and based on motivational interviewing
 Behavioral: Counselor delivered brief intervention
This is a one session brief intervention delivered in a primary care setting that is based on motivational interviewing.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 3 months post-baseline ]
    The ASSIST's Global Continuum of Illicit Drug Risk was used. A higher score is considered more severe risk. The scores range from 0 to 308.

  2. Hair Testing [ Time Frame: 3 month post-baseline ]
    The number of participants testing positive on Radioimmunoassay (RIA) Hair Testing for opiates, cocaine, amphetamine and tetrahydrocannabinol (THC)


Secondary Outcome Measures :
  1. Human Immunodeficiency Virus (HIV) Drug Use Risk Assessment Battery Subscale [ Time Frame: 3 months post-baseline ]
    HIV Drug Use Risk Assessment Battery Subscale Score ranges from 0 to 22. A higher score is considered to be associated with higher risk.

  2. Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 6 month post-baseline ]
    ASSIST's Global Continuum of Illicit Drug Risk Score which ranges from 0 to 308. A higher score is associated with higher risk.

  3. Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 12 months post-baseline ]
    ASSIST's Global Continuum of Illicit Drug Risk Score which ranges from 0 to 308. A higher score is associated with higher risk.

  4. Hair Testing [ Time Frame: 6 month post-baseline ]
    The predicted probabilities for testing positive on Radioimmunoassay (RIA) Hair Testing for opiates, cocaine, amphetamine and tetrahydrocannabinol (THC), calculated from generalized estimating equations.

  5. Hair Testing [ Time Frame: 12 month post-baseline ]
    Predicted Probabilities for testing positive on the Radioimmunoassay (RIA) Hair Testing for opiates, cocaine, amphetamine and THC, calculated from generalized estimating equations.

  6. Human Immunodeficiency Virus (HIV) Risk Assessment Battery Subscale [ Time Frame: 6 month post-baseline ]
    HIV Drug Use Risk Assessment Battery Subscale Score ranges from 0 to 22. A higher score is considered to be associated with higher risk.

  7. Human Immunodeficiency Virus (HIV) Risk Assessment Battery Subscale Score [ Time Frame: 12 month post-baseline ]
    HIV Drug Use Risk Assessment Battery Subscale Score ranges from 0 to 22. A higher score is considered to be associated with higher risk.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 years or older
  • Moderate risk category on the ASSIST scores

Exclusion Criteria:

  • planning to move out of New Mexico in the next year
  • receipt of formal drug abuse treatment or a brief intervention for drug use in the past month.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01131520


Locations
United States, Maryland
Friends Research Institute
Baltimore, Maryland, United States, 21201
Sponsors and Collaborators
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Robert P Schwartz, M.D. Friends Research Institute, Inc.
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Friends Research Institute, Inc.
ClinicalTrials.gov Identifier: NCT01131520     History of Changes
Other Study ID Numbers: 08-08-173
R01DA026003 ( U.S. NIH Grant/Contract )
First Posted: May 27, 2010    Key Record Dates
Results First Posted: August 21, 2017
Last Update Posted: December 12, 2017
Last Verified: November 2017

Keywords provided by Friends Research Institute, Inc.:
SBIRT
Drug abuse

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders